Affimed N.V. (NASDAQ:AFMD) Q2 2023 Earnings Call Transcript August 10, 2023 8:30 AM ET

Company Participants

Alex Fudukidis - Director of Investor Relations

Adi Hoess - Chief Executive Officer

Andreas Harstrick - Chief Medical Officer

Angus Smith - Chief Financial Officer

Wolfgang Fischer - Chief Operating Officer

Arndt Schottelius - Chief Scientific Officer

Conference Call Participants

Maurice Raycroft - Jefferies

Daina Graybosch - Leverink Partners

Li Watsek - Cantor Fitzgerald

Yale Jen - Laidlaw & Co

Yanan Zhu - Wells Fargo Securities

Srikripa Devarakonda - Truist Securities

Andy Chen - Berenberg

Operator

Good day, everyone, and welcome to Affimed’s Second Quarter 2023 Earnings and Corporate Update Call. As a reminder, today's conference call is being recorded.

I would now like to introduce your host for today's call, Alex Fudukidis, Head of Investor Relations at Affimed. Please go ahead.

Alex Fudukidis

Thank you, Chris, and thank you all for joining us today for our second quarter 2023 update call. Before we begin, I'd like to remind everyone that we issued the relevant press release and presentation earlier today, which can be found on the Investor Relations section of our website.

On the call today, we have the members of our management team, including our Chief Executive Officer, Adi Hoess; Andreas Harstrick, our Chief Medical Officer; Arndt Schottelius, our Chief Scientific Officer; Wolfgang Fischer, our Chief Operating Officer; and Denise Mueller, our Chief Business Officer; and Angus Smith, our Chief Financial Officer. The team will be available for Q&A after the prepared remarks.

Before we start, I'd like to remind everyone that today's presentation contains projections and forward-looking statements regarding future events. These statements represent our belief and assumptions as -- only as of the date of this call. Except as required by law, we assume no obligation to update these forward-looking statements publicly or to update the reasons why actual results could differ materially from those anticipated in the forward-looking statements, even if new information becomes available in the future. These forward-looking statements are subject to risks and uncertainties and actual results may differ materially from those expressed or implied in these statements due to various factors including, but not limited to, those identified under the section entitled Risk Factors in our filings with the SEC, and those identified under the section entitled Forward-Looking Statements in the press release that we issued today and filed with the SEC.

With that, I'll turn the call over to Adi. Adi?